These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31531761)

  • 1. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection.
    Zhang X; Bai Y; Xu L; Zhang B; Feng S; Xu L; Zhang H; Xu L; Yang P; Niu T; Zheng S; Liu J
    Hepatol Int; 2019 Nov; 13(6):715-725. PubMed ID: 31531761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
    Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
    Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
    Liu WR; Tian MX; Tang Z; Fang Y; Zhou YF; Song SS; Jiang XF; Wang H; Tao CY; Zhou PY; Qu WF; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
    Br J Cancer; 2020 Jul; 123(1):92-100. PubMed ID: 32376890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.
    Kim JM; Kwon CH; Joh JW; Ko JS; Park JB; Lee JH; Kim SJ; Paik SW; Park CK
    World J Surg Oncol; 2013 Apr; 11():92. PubMed ID: 23618082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
    Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
    Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.
    Hao K; Luk JM; Lee NP; Mao M; Zhang C; Ferguson MD; Lamb J; Dai H; Ng IO; Sham PC; Poon RT
    BMC Cancer; 2009 Nov; 9():389. PubMed ID: 19886989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.
    Zhang Z; Weng W; Huang W; Wu B; Zhou Y; Zhang J; Deng T; Ye W; Zhang J; Ao J; Zhang Q; Shi K
    Aging (Albany NY); 2020 Jun; 12(13):12896-12920. PubMed ID: 32611831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
    Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma.
    Nanashima A; Morino S; Yamaguchi H; Tanaka K; Shibasaki S; Tsuji T; Hidaka S; Sawai T; Yasutake T; Nakagoe T
    Eur J Surg Oncol; 2003 Nov; 29(9):735-42. PubMed ID: 14602492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
    Kim HS; Yi NJ; Kim JM; Hong SK; Kwon CHD; Joh JW; Lee KW; Suh KS
    ANZ J Surg; 2019 Mar; 89(3):216-222. PubMed ID: 30384395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.